Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin

NCT: NCT07006896 · ACTIVE_NOT_RECRUITING

NCT IDNCT07006896
StatusACTIVE_NOT_RECRUITING
Start Date2025-07-10
Completion2027-05-01
SponsorUniversity of Pennsylvania (OTHER)
First posted
Last updated

Brief Summary

A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.

Frequently Asked Questions

What is Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin?

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin is a clinical trial registered under NCT07006896. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07006896?

The current status of NCT07006896 (Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin) is: ACTIVE_NOT_RECRUITING.

When did Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin start?

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin started on 2025-07-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.